These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38862179)

  • 41. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial.
    Baos S; Underwood W; Culliford L; Reeves BC; Rogers CA; Bowles R; Johnson T; Baumbach A; Mumford A
    Trials; 2017 Nov; 18(1):529. PubMed ID: 29121979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ticagrelor With or Without Aspirin After Complex PCI.
    Dangas G; Baber U; Sharma S; Giustino G; Mehta S; Cohen DJ; Angiolillo DJ; Sartori S; Chandiramani R; Briguori C; Dudek D; Escaned J; Huber K; Collier T; Kornowski R; Kunadian V; Kaul U; Oldroyd K; Sardella G; Shlofmitz R; Witzenbichler B; Ya-Ling H; Pocock S; Gibson CM; Mehran R
    J Am Coll Cardiol; 2020 May; 75(19):2414-2424. PubMed ID: 32240761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
    Mehran R; Baber U; Sharma SK; Cohen DJ; Angiolillo DJ; Briguori C; Cha JY; Collier T; Dangas G; Dudek D; Džavík V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta SR; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM
    N Engl J Med; 2019 Nov; 381(21):2032-2042. PubMed ID: 31556978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis.
    Agrawal A; Kumar A; Majid M; Badwan O; Arockiam AD; El Dahdah J; Syed AB; Schleicher M; Reed GW; Cremer PC; Griffin BP; Menon V; Wang TKM
    Heart; 2024 Feb; 110(5):323-330. PubMed ID: 37648436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effectiveness of clopidogrel versus aspirin as a maintenance monotherapy 1 year after coronary artery bypass grafting.
    Kim JS; Kang Y; Sohn SH; Hwang HY
    Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 37039835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Serruys PW; Takahashi K; Chichareon P; Kogame N; Tomaniak M; Modolo R; Chang CC; Komiyama H; Soliman O; Wykrzykowska JJ; de Winter RJ; Ferrario M; Dominici M; Buszman P; Bolognese L; Tumscitz C; Benit E; Stoll HP; Hamm C; Steg PG; Onuma Y; Jüni P; Windecker S; Vranckx P; Colombo A; Valgimigli M
    Eur Heart J; 2019 Aug; 40(31):2595-2604. PubMed ID: 31397487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
    Kim CJ; Park MW; Kim MC; Choo EH; Hwang BH; Lee KY; Choi YS; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Seung KB; Jeong MH; Yim HW; Ahn Y; Chang K;
    Lancet; 2021 Oct; 398(10308):1305-1316. PubMed ID: 34627490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME
    J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
    Gao C; Tomaniak M; Takahashi K; Kawashima H; Wang R; Hara H; Ono M; Montalescot G; Garg S; Haude M; Slagboom T; Vranckx P; Valgimigli M; Windecker S; van Geuns RJ; Hamm C; Steg PG; Onuma Y; Angiolillo DJ; Serruys PW
    Cardiovasc Diabetol; 2020 Oct; 19(1):179. PubMed ID: 33066794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial.
    Vranckx P; Valgimigli M; Windecker S; Steg PG; Hamm C; Jüni P; Garcia-Garcia HM; van Es GA; Serruys PW
    EuroIntervention; 2016 Nov; 12(10):1239-1245. PubMed ID: 26606735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Ono M; Onuma Y; Kawashima H; Hara H; Gao C; Wang R; O'Leary N; Benit E; Janssens L; Ferrario M; Żurakowski A; Dominici M; Huber K; Buszman P; Garg S; Wykrzykowska JJ; Piek JJ; Jüni P; Hamm C; Windecker S; Vranckx P; Deliargyris EN; Bhatt DL; Storey RF; Valgimigli M; Serruys PW;
    Catheter Cardiovasc Interv; 2022 Jul; 100(1):72-82. PubMed ID: 35500171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.
    Zhao G; Zhou M; Ma C; Huo Y; Smith SC; Fonarow GC; Ge J; Han Y; Liu J; Hao Y; Liu J; Wang X; Taubert KA; Morgan L; Zhao D; Nie S;
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29602767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
    Saw J; Wong GC; Mayo J; Bernstein V; Mancini GB; Ye J; Skarsgard P; Starovoytov A; Cairns J
    Heart; 2016 May; 102(10):763-9. PubMed ID: 26891756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial.
    Johnson TW; Baos S; Collett L; Hutchinson JL; Nkau M; Molina M; Aungraheeta R; Reilly-Stitt C; Bowles R; Reeves BC; Rogers CA; Mundell SJ; Baumbach A; Mumford AD
    J Am Heart Assoc; 2020 Dec; 9(24):e016495. PubMed ID: 33305660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton pump inhibitor in the prevention of upper gastrointestinal mucosal injury associated with dual antiplatelet therapy after coronary artery bypass grafting (DACAB-GI-2): study protocol for a randomized controlled trial.
    Zhu Y; Wang X; Yang Y; Liu L; Zhao Q; Yu L
    Trials; 2022 Jul; 23(1):569. PubMed ID: 35840999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
    N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial.
    Lee B; Lee SJ; Kim BK; Lee YJ; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):e218-e226. PubMed ID: 37021576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.